D69.1

Applicable To

• Bernard-Soulier [giant platelet] syndrome

• Glanzmann’s disease

• Grey platelet syndrome

• Thromboasthenia hemorrhagic) hereditary)

• Thrombocytopathy

Approximate Synonyms

• Platelet disorder

• Platelet disorder, qualitative

• Platelet dysfunction due to drugs

• Platelet dysfunction, drug induced

• Qualitative platelet disorder

Clinical Information

• A congenital bleeding disorder with prolonged bleeding time, absence of aggregation of platelets in response to most agents, especially adp, and impaired or absent clot retraction. Platelet membranes are deficient in or have a defect in the glycoprotein iib-iiia complex platelet glycoprotein gpiib-iiia complex).

• A rare inherited bleeding disorder characterized by the decrease or absence of the platelet alpha-granules and their proteins in the peripheral blood platelets.

• A rare, autosomal recessive inherited and less frequently acquired platelet disorder. It is characterized by deficient or dysfunctional glycoprotein iib/iiia complex. It leads to defective platelet aggregation, resulting in bleeding.

• A rare, inherited platelet disorder characterized by a selective deficiency in the number and contents of platelet alpha-granules. It is associated with thrombocytopenia, enlarged platelets, and prolonged bleeding time.

• Platelet abnormality characterized by defective clot formation, impaired aggregation, and prolonged bleeding time; other manifestations include nosebleeds, inappropriate bruising, and excessive bleeding.

Details

• D69.1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.

• The 2023 edition of ICD-10-CM D69.1 became effective on October 1, 2022.

• This is the American ICD-10-CM version of D69.1 – other international versions of ICD-10 D69.1 may differ.